Canaccord Adams Upgrades ArthroCare (ARTC) to Buy; Positive on Equity Investment
Tweet Send to a Friend
Canaccord Adams upgrades ArthroCare (OTC: ARTC) from Speculative Buy to Buy. Price target increased to $21.00 from $15.25.
Canaccord analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Canaccord analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
